Alcon Buys Ophthalmology Assets from Sirion
By Taskin Ahmed
Pharma Deals Review: Vol 2010 Issue 1 (Table of Contents)
Published: 25 Jan-2010
DOI: 10.3833/pdr.v2010.i1.1305 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
To expand its marketed and pipeline product portfolio, Alcon entered into an agreement to acquire the rights to two products, Durezol™ (difluprednate ophthalmic emulsion) and Zirgan™ (ganiciclovir ophthalmic gel) from Sirion Therapeutics...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS